Page results
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
A new service to provide comprehensive care and support for patients living with Sickle Cell disorder is now available in the comfort of their homes thanks to a partnership between UCLH and Whittington Health NHS Trusts.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
UCLH’s Ela Biel has won a national prize for domestics with judges noting her care in protecting vulnerable patients and using her own cancer journey to empathise with cancer patients who are often more vulnerable to and anxious about infection.
-
This page tells you about the procedure known as a renal cryoablation. It explains what is involved and what the possible risks are.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
The children and young people's division at UCLH are running two events for young people aged 13 - 24 years.
File results
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023
-
FOI/2023/0352 - Security training/ Data breaches/ Security budgets/ Digital cyber security services
-
FOI/2023/0280 - Psychiatric inpatient wards - parental and family
-
FOI/2023/0281 - Bariatric equipment